We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > News > Science & Health > Content Piece

University of Westminster to Hold Public Lecture on Use of Cannabis in the Treatment of Epilepsy

Published: Sep 04, 2017   
Listen with
Register for FREE to listen to this article
Thank you. Listen to this article using the player above.

The University of Westminster’s Research Center for Optimal Health is organizing a Public Lecture titled ‘Cannabis and Epilepsy: Past, Present and Future’ on 18 October, with Professor Geoffrey Guy from GW Pharma as keynote speaker.

Epilepsy is a devastating neurological condition that has affected humanity from time immemorial. Treatment throughout this time has been wide-ranging in nature, with varied level of success. More recently there has been a resurgence in the interest in the use of cannabis in the treatment of epilepsy. A number of clinical trials, with cannabis derived compounds such as Cannabidiol (CBD) having significant therapeutic benefits in neurologic conditions such as epilepsy. However, there still is a significant research paucity in our understanding of the use of medical cannabis in epilepsy.

In this free half-day evening symposium on the University’s Cavendish Campus in Fitzrovia, Central London, Professor Geoffrey Guy will give a historical overview of the use of cannabis and cannabis derived products in the treatment of epilepsy and will present and discuss the latest research in this sometime contentious, yet rapidly expanding, area of social, scientific and medical importance.

Professor Geoffrey Guy is the founder and owner of GW Pharma, a highly successful biotech company and one of the world leaders in the development and commercialization of herb-derived medicines, including cannabinoids. Professor Guy is also an outstanding scientist who has worked closely with leading scientific institutions, including the University of Westminster, in determining the mode-of-action of some of these natural compounds and their effects on health and disease. He has published widely, with many highly cited papers and reviews in the area of cannabinoids and mitochondrial function.

Professor Guy has been collaborating with the University of Westminster researching the role of quantum optimization in health and disease. This area of research is looking at how quantum effects can be used to help optimize life conditions for living systems.

Professor Guy is in the unique position of having successfully brought to market medicines derived from plants; an experience that is invaluable to the search for new medicines. Moreover, his in-depth knowledge of the biotech market and medical community is highly relevant to many sectors of society including Medicine, Business and the Social Sciences.

Professor Jimmy Bell from the University of Westminster’s Research Center for Optimal Health who is the organizer of this Public Lecture, said: “Understanding and adapting to global research challenges will be key to deliver the next revolution in medicine.”

The evening lecture will take place between 6.30-8pm on Wednesday 18 October at the University of Westminster’s Cavendish Campus at 115 New Cavendish Street, London, W1W 6UW.

This article has been republished from materials provided by University of Westminster. Note: material may have been edited for length and content. For further information, please contact the cited source.


Like what you just read? You can find similar content on the topic tag shown below.

Science & Health

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter